THE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia

Similar documents
Valve Analysis and Pathoanatomy: THE MITRAL VALVE

Posterior leaflet prolapse is the most common lesion seen

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Surgical Repair of the Mitral Valve Presenter: Graham McCrystal Cardiothoracic Surgeon Christchurch Public Hospital

Repair or Replacement

Choosing the Right Treatment for Primary Mitral Regurgitation ΓΡΗΓΟΡΙΟΣ ΠΑΤΤΑΚΟΣ, MD, MS Καρδιοχειρουργός Β Κ/Χ Κλινικής Αναπλ. Διευθ.

Basic principles of Rheumatic mitral valve Repair

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

NeoChord Mitral Valve Repair. Department of Cardiac, Thoracic and Vascular Sciences University of Padua, Italy

The clinical problem of atrioventricular valve regurgitation

Quality Outcomes Mitral Valve Repair

Eva Maria Delmo Walter Takeshi Komoda Roland Hetzer

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

MitraClip in the ICCU: Which Patient will Benefit?

8/31/2016. Mitraclip in Matthew Johnson, MD

MR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras

The Edge-to-Edge Technique f For Barlow's Disease

Really Less-Invasive Trans-apical Beating Heart Mitral Valve Repair: Which Patients?

Transcatheter Echo Guided Mitral Valve Repair with NeoChord Implantation: Results from NeoChord Independent International Registry

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Comparison of outcomes of minimally invasive mitral valve surgery for posterior, anterior and bileaflet prolapse

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

Cases of mitral valve causing mitral regurgitation: the MV prolapse spectrum CASE

Aortic valve repair: When and how to employ this novel approach?

Atrioventricular valve repair: The limits of operability

Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας

Percutaneous Mitral Valve Repair

Echocardiographic Evaluation of Primary Mitral Regurgitation

DECISION MAKING DEL CARDIOCHIRURGO NELL INSUFFICIENZA MITRALICA: ISTRUZIONI D USO D CARDIOLOGO

Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired?

Results of Aortic Valve Preservation and Repair

Management of Incomplete Initial Repair in the Treatment of Degenerative Mitral Insufficiency An Institutional Protocol and Mid-Term Outcomes

Surgical repair techniques for IMR: future percutaneous options?

Historical perspective R1 黃維立

Use of MitraClip Beyond Everest Criteria

What echo measurements are key prior to MitraClip?

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Chordae replacement versus leaflet resection in minimally invasive mitral valve repair

Hani K. Najm MD, Msc, FRCSC, FRCS (Glasgow), FACC, FESC President of Saudi Heart Association King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia.

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

The HRT Mitral Bridge Technology for Functional MR

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Myxomatous degeneration of the mitral valve is the

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Organic mitral regurgitation

Technical aspects of robotic posterior mitral valve leaflet repair

Basic Principles of Degenerative Mitral Valve Repair Technical Aspects and Results. Manuel Antunes Coimbra-Portugal

Transcatheter Mitral Valve Interventions: Clinical Indications. Didier TCHETCHE, MD. Clinique Pasteur, Toulouse, France.

Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation

2017 Cardiovascular Symposium CARDIAC SURGERY UPDATE: SMALLER INCISIONS AND LESS COUMADIN DAVID L. SAINT, MD

Ischemic Mitral Regurgitation

Iatrogenic pathology of the heart:

Minimally invasive valve sparing mitral valve repair the loop technique how we do it

ICE: Echo Core Lab-CRF

MEMO 4D Reshaping Mitral Repair

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain

Correction of anterior mitral prolapse: The parachute technique

Transthoracic Echocardiographic

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

MEMO 3D. The true reflection of the mitral annulus. Natural physiological 3D motion

Incidence of Postoperative Atrial Fibrillation after minimally invasive mitral valve surgery

Ann Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article

What is the Role of Surgical Repair in 2012

The correlation between the coaptation height of mitral valve and mitral regurgitation after mitral valve repair

Rheumatic fever and rheumatic heart disease still remain a. The Rheumatic Mitral Valve and Repair Techniques in Children. Afksendiyos Kalangos

What s New in Mitral Valve Repair?

Midterm Outcomes Using the Physio Ring in Mitral Valve Reconstruction: Experience in 492 Patients

MITRAL STENOSIS. Joanne Cusack

Transapical beating-heart chordae implantation in mitral regurgitation: a new horizon for repairing mitral valve prolapse

Percutaneous Mitral Valve Repair

Lessons From The Computer Model and How We Do Root Replacement

Mitral Valve Disease, When to Intervene

Clinical material and methods. Copyright by ICR Publishers 2007

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Lifting posterior mitral annuloplasty for enhancing leaflet coaptation in mitral valve repair: midterm outcomes

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Tricuspid leaflet repair: innovative solutions

Despite advances in our understanding of the pathophysiology

Mechanism of and Risk Factors for Reoperation After Mitral Valve Repair for Degenerative Mitral Regurgitation

Index. B B-type natriuretic peptide (BNP), 76

Challenging Case. 77 year old man 1/24/2018. Two months PTA AVR with 21 Edwards Magna and VSD repair for S. Aureus endocarditis

Current status: Percutaneous mitral valve therapy

Degenerative mitral valve disease is the leading cause of

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25-year experience

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC

MITRAL REGURGITATION ECHO PARAMETERS TOOL

Aortic Valve Repair: The Brussels Approach Laurent de Kerchove, MD, PhD Cliniques Universitaires St-Luc, IREC, UCL, Brussels, Belgium

When Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea

Reconstruction of the Aortic Valve and Root A Practical approach Failures after aortic valve repair. Diana Aicher. September 16 th -18 th 2015

Understanding the guidelines for Interventions in MR. Ali AlMasood

2/7/2018. Minimally-invasive Mitral Valve surgery at NYU

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

Anterior Mitral Leaflet Prolapse as a Primary Cause of Pure Rheumatic Mitral Insufficiency

Transcription:

THE FOLDING LEAFLET Rafael García Fuster Cardiac Surgery Department University General Hospital of Valencia School of Medicine Catholic University of Valencia San Vicente Mártir SPAIN

Carpentier s principles of a reconstructive valve operation 1.Preserve or restore FULL LEAFLET MOTION 2. LARGE SURFACE OF COAPTATION 3. Remodel-stabilize THE ENTIRE ANNULUS

1.FULL LEAFLET MOTION Respect rather than resect --NO neochordal shortening (the key-point: neochordal height adjustment) 2. REMODEL THE LEAFLET -large surface of coaptation -avoid SAM in case of excess of tissue 3. REMODEL THE ENTIRE ANNULUS

FULL LEAFLET MOTION with leaflet restrictive techniques? Posterior leaflet restriction Bileaflet restriction

Patrick Perier s new paradigm but without neochordal shortening in order to avoid posterior leaflet restriction RESPECT BOTH, *LEAFLET TISSUE AND *LEAFLET MOBILITY

1. FULL LEAFLET MOTION Remodel the leaflet avoiding neochordal shortening FROZEN POSTERIOR LEAFLET MOBILE POSTERIOR LEAFLET 2. REMODEL THE LEAFLET

Remodel the leaflet fixing the neochordae along the rough zone Hockey-stick effect - > SURFACE OF COAPTATION

fixing the neochordae along the rough zone

Ventricular view of anterior leaflet

Ventricular view of anterior leaflet

Ventricular view of anterior leaflet

Coaptation line

Coaptation line

Coaptation line Smooth zone Rough zone

Coaptation line Smooth zone Rough zone

Hockey-stick effect on the leaflets

(Rough zone)

Remodel the leaflet to avoid SAM in case of excess of tissue Atrial surface Atrial surface

Avoid SAM Global bileaflet atrial surface Prosthetic ring internal área tailoring the Global Bileaflet Atrial Surface to the ring Prosthetic ring internal área 1. Remodel the leaflet 2. Height of posterior leaflet 15mm 3. Physio II

ATRIAL SURFACE Approaching the excess of tissue with neochordae AVOIDING SAM

REMODEL THE LEAFLETS WITH NEOCHORDAE <<<< ATRIAL SURFACE >>>> SURFACE OF COAPTATION

>>>> internal oriffice area Annuloplasty ring <<<< ATRIAL SURFACE >>>> SURFACE OF COAPTATION

Avoid excessive anterior displacement of the coaptation line (2/3 1/3 proportion) 2/3 Avoid excessive remodeling 1/3 Height 15mm

the key-point: neochordal height adjustment FOLDING LEAFLET

Put the knot at the level of the annulus MARGINAL = BASAL PAPILLARY MUSCLE while the leaflet is completely folded

POSTERIOR AND ANTERIOR LEAFLET NEOCHORDAL RECONSTRUCTION

Papillary muscle variability --- Loop technique? Carpentier s Classification

Loop technique --- papillary muscle variability Carpentier s Classification x x

A1 A2 (A) A2 (P) A3 AC PC A2 (P) A3 PC P1 P2 (P) P3 P3 P2 (A) P2 (P) Neochordal arrangement

A1 A2 (A) A2 (P) A3 AC PC A2 (P) A3 PC P1 P2 (P) P3 P3 P2 (A) P2 (P) Neochordal arrangement

1. Annuloplasty sutures for a good exposure 2. Exploration: isolation of the prolapsing área (5/0 prolene suture) 3. Identify the coaptation line --- between rough and smooth zone 4. Folding sutures from the coaptation line to the annulus ( folding ) 5. Neochordae fixation across the corresponding papillary muscle 6. Neochordae fixation across the rough zone of the leaflet (remodeling) 7. Neochordal height adjustment ( knot at the level of the annulus ) 8. Unfolding and testing 9. Ring implantation 10. Final testing. SYSTEMATIC APPROACH FOR NEOCHORDAL REPAIR

VIDEO 3 DISTINTOS PROLAPSOS

TOTAL NEOCHORDAL RECONSTRUCTION A1 A2 A3 P1 P3 P2

COMPLETE MV RECONSTRUCTION Wetlab on human heart

THE FOLDING LEAFLET TECHNIQUE MIDTERM OUTCOMES

MIDTERM OUTCOMES 100 patients 10 years follow-up ONLY one surgeon ONLY MV repair ONLY one technique --- neochordal repair MAINLY degenerative MR

Variable Preoperative characteristics n=104 patients Study period: Feb 2009 June 2018 One surgeon Folding leaflet technique n (%) / x±sd Age (y) 64±11 (26-83) Female sex 36 (34.6) NYHA class -I 9 (8.7) -II 59 (56.7) -III 32 (30.8) -IV 4 (3.8) Hypertension 62 (59.6) Diabetes 22 (21.2) CRF 3 (2.9) COPD 22 (21.2) Stroke 4 (3.8) AF 36 (34.6) EuroSCORE II 5.2±2.5 (2-14)

Preoperative characteristics 60 53 patients MR Etiology *Rheumatic: 4 50 40 38 patients *Endocarditis: 6 *Ischemic: 1 *Congenital: 1 30 *Trauma: 1 20 13 patients 10 0 FED Barlow Other

Pattern of lesions BARLOW A2 P3 FED P2 P2

Posterior leaflet prolapse -- n=58 patients Multiscalloped prolapse n=30 patients Annulus calcification n= 8 patients

n=21 pat *Barlow: 8 *FED: 10 *endocard: 3 P2 P3 n=14 pat *Barlow: 6 *FED: 8 P2 P1 P2 P3 n=7 pat *Barlow: 4 *FED: 2 *Rheum: 1

P3 n=5 pat *FED: 5 P1 n=2 pat *FED: 2 P1 P2 n=9 pat *Barlow: 4 *FED: 4 *Endocard: 1

Anterior leaflet prolapse -- n=27 patients Multisegment prolapse n=17 patients Annulus calcification n= 1 patient

A2 n=8 pat *FED: 5 *Rheumat: 1 *Trauma: 1 *Congenit: 1 A2 A3 n=9 pat *Barlow: 4 *FED: 5 A1 A2 A3 n=8 pat *Barlow: 2 *FED: 5 *Rheumat: 1

A3 n=2 pat *FED: 1 *Ischemic: 1 (PM elongat)

Bileaflet prolapse n=19 patients Anterior Commissural prolapse n=8 patients Posterior Commissural prolapse n=15 patients Annulus calcification n= 4 patients

A2 n=4 pat *Barlow: 1 *FED: 1 *Endocard: 2 P2 A2 A3 P3 n=4 pat *Barlow: 2 *FED: 2 P2 A2 P2 P3 n=1 pat *Barlow: 1

A2 A3 n=1 pat *Barlow: 1 P2 A1 A2 A3 n=1 pat *FED: 1 P2 P1 A1 A3 A2 P3 n=5 pat *Barlow: 5 P2

A3 P3 n=1 pat *FED: 1 P1 A1 A2 n=2 pat *FED: 1 *Rheumat: 1

Intraoperative variables Variable n (%) / x±sd Median sternotomy 100% PTFE neochordae 100% Annuloplasty ring 100% -CE Physio 63 (60.6) size (mm) 28±6 (26-30) -CE Physio II 41 (39.4) size (mm) 30±4 (28-34) Indentation closure 14 (13.5) (posterior flail leaflet) Maze procedure 24 (23.1) Atrial appendage closure 12 (11.5) CPB time 143±34 (90-192) Cross-Clamp time 115±29 (52-135)

Outcomes In-hospital mortality: 2 / 104 patients (1.9%) Causes of death: distress (1) sepsis (1) Late mortality: 4 / 102 patients (3.9%) Causes of death: Pneumonia (1) ARF (1) Tumoral disease (1) Unknown (1)

Survival Study period: Feb 2009 June 2018 (2 months 9 years 6 months) 91±0.4% 109.3±2.2 months (104.8 113.7) Patients at risk: 102 82 70 44 24 7

Reoperation: 3 patients *Non-valve related: -postcardiotomy síndrome: 1 --- after 1 month *Valve related: -Mitral stenosis: 1 --- after 3 years (rheumatic disease) -Endocarditis: 1 --- after 12 months

Reoperation: 3 patients 97±0.01% Patients at risk: 102 82 69 44 26 8

Qx 1st month 6th month 1st year Annually Systematic Echo follow-up

Recurrence of MR > 2+ 4+ MR: 2 patients Causes: -AL chordal ruptura (endocarditis) -P3 retraction by annulus calcification 3+ MR: 5 patients Causes: -PL restriction + moderate MS (rheum) -PL restriction (annulus calcification) -traumatic elongation of anterior PM -excessive remodeling of AL -commissural jet (large previous AL prolapse).

Grade of MR at latest Echo follow-up 70 60 Excluded: MV REDO (2) + Dead patients (6) n=57 (59.4%) 50 40 30 20 10 0 n=25 (26%) n=9 (9.4%) n=4 (4.2%) n=1 (1%) 0 MR 1+ MR 2+ MR 3+ MR 4+ MR

Recurrence of MR > 2+ 89±0.3% Patients at risk: 102 83 71 43 26 9

Echo parameters at follow-up 70 60 50 40 30 20 10 0 p<0.0001 preop 6 month 1 year late LVEF EDLVD PSP ESLVD

Echo parameters at follow-up 70 60 50 40 55±6 49±5 47±4 46±5 EDLVD (mm) 30 20 10 0 34±6 31±5 30±5 29±5 p<0.0001 preop 6 month 1 year late ESLVD (mm)

Echo parameters at follow-up 70 60 50 40 56±5 59±6 61±5 62±7 p<0.0001 LVEF (%) 30 20 10 0 preop 6 month 1 year late

Echo parameters at follow-up 70 60 50 46±1 40 30 20 10 0 32±6 31±7 31±9 p<0.0001 preop 6 month 1 year late PSP (mmhg)

EDLVD (mm) One-way ANOVA with repeated measures p<0.001 70 60 50 40 55±6 55±5 48±4 49±5 2+ MR 48±5 50±5 47±4 46±5 30 20 0-1+ MR 10 0 preop 6 month 1 year late

ESLVD (mm) One-way ANOVA with repeated measures p=0.24 70 60 50 40 30 34±9 2+ MR 31±6 32±6 31±6 20 10 0 33±5 32±5 29±5 29±5 0-1+ MR preop 6 month 1 year late

PSP (mmhg) One-way ANOVA with repeated measures p<0.0001 70 60 50 40 48±1 33±5 36±7 2+ MR 41±9 30 20 46±1 32±7 29±5 29±8 10 0-1+ MR 0 preop 6 month 1 year late

70 60 LVEF (%) 56±5 One-way ANOVA with repeated measures p=0.17 0-1+ MR 60±5 62±5 63±6 50 40 30 54±8 58±8 58±7 58±9 2+ MR 20 10 0 preop 6 month 1 year late

CONCLUSIONS -1. Neochordal repair with the Folding Leaflet Technique has achieved excellent results. -2. This technique is suitable for complex repairs: a great variety of complex lesions can be managed. -3. Excellent results at follow-up ( 10 years), especially in degenerative MR: *a large percentage of patients with absent MR and preservation of bileaflet mobility *good regression of LV diametres and PSP *improvement to normal values of LVEF.

THE FOLDING LEAFLET Rafael García Fuster Cardiac Surgery Department University General Hospital of Valencia School of Medicine Catholic University of Valencia San Vicente Mártir SPAIN